article Open AccessTop 1% cited

Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease

Archives of Neurology · 2006 · Vol. 63(7) · pp. 969–969

Daniel Weintraub✉(Parkinson's UK)Andrew SiderowfMarc N. PotenzaJoseph S. GoveasKnashawn H. MoralesJohn E. DudaPaul J. MobergMatthew B. Stern

View via DOI Publisher page

Abstract

Patients with PD treated with a dopamine agonist should be made aware of the risk of developing an ICD and monitored clinically. Because dopamine agonists are increasingly being used for other indications, future research should assess the dopamine agonist-associated risk for ICDs in other populations.

Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Obsessive-Compulsive Spectrum DisordersDopamine agonistDopamineHypersexualityAgonistMedicineParkinson's diseaseInternal medicineImpulse control disorderRopinirolePsychology

MeSH terms

PramipexoleAdultAgedAged, 80 and overFemaleFollow-Up StudiesGamblingHumansDisruptive, Impulse Control, and Conduct DisordersIndolesMaleMiddle AgedParkinson DiseasePergolideRisk Factors

Citations

659

FWCI

29.10

field-weighted impact

References

Percentile

100%

vs. same field & year

Citations per year

Cited by

The <i>Movement</i> Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease